Cargando…
Congenital Adrenal Hyperplasia Presenting as Pulseless Ventricular Tachycardia in a Neonate
Congenital adrenal hyperplasia (CAH) comprises a group of autosomal recessive inherited disorders that arise due to defects in one of the enzymes of steroidogenesis pathway in the adrenal glands. Ninety-five percent of the cases occur due to deficiency in 21-hydroxylase (21-OH). Clinically, CAH due...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663285/ https://www.ncbi.nlm.nih.gov/pubmed/31363431 http://dx.doi.org/10.7759/cureus.4749 |
_version_ | 1783439778028453888 |
---|---|
author | Manzoor, Nida Minhaj, Areeba Akmal, Manahil |
author_facet | Manzoor, Nida Minhaj, Areeba Akmal, Manahil |
author_sort | Manzoor, Nida |
collection | PubMed |
description | Congenital adrenal hyperplasia (CAH) comprises a group of autosomal recessive inherited disorders that arise due to defects in one of the enzymes of steroidogenesis pathway in the adrenal glands. Ninety-five percent of the cases occur due to deficiency in 21-hydroxylase (21-OH). Clinically, CAH due to 21-OH deficiency presents in two distinct forms, classic CAH and non-classic CAH. Females with classical forms present with genial ambiguity while the presentation in males is more subtle with severe electrolyte disturbances being the initial manifestation in many cases. Arrhythmias are a rare manifestation of CAH. We report the case of an 18-day-old male child who presented with pulseless ventricular tachycardia and was later diagnosed with congenital adrenal hyperplasia based on the laboratory findings of elevated 17-hydroxyprogesterone (17-OHP) levels. Our case reveals that fatal arrhythmias such as a pulseless ventricular tachycardia can be the primary manifestation of the adrenal insufficiency of CAH even in the absence of any physical findings and hence clinicians should always maintain a strong suspicion for CAH in any child presenting with unexplained arrhythmia. Furthermore, this case also highlights the need for CAH screening in neonates so that the appropriate hormone replacement can be initiated before the development of life-threatening adrenal crisis. |
format | Online Article Text |
id | pubmed-6663285 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-66632852019-07-30 Congenital Adrenal Hyperplasia Presenting as Pulseless Ventricular Tachycardia in a Neonate Manzoor, Nida Minhaj, Areeba Akmal, Manahil Cureus Cardiology Congenital adrenal hyperplasia (CAH) comprises a group of autosomal recessive inherited disorders that arise due to defects in one of the enzymes of steroidogenesis pathway in the adrenal glands. Ninety-five percent of the cases occur due to deficiency in 21-hydroxylase (21-OH). Clinically, CAH due to 21-OH deficiency presents in two distinct forms, classic CAH and non-classic CAH. Females with classical forms present with genial ambiguity while the presentation in males is more subtle with severe electrolyte disturbances being the initial manifestation in many cases. Arrhythmias are a rare manifestation of CAH. We report the case of an 18-day-old male child who presented with pulseless ventricular tachycardia and was later diagnosed with congenital adrenal hyperplasia based on the laboratory findings of elevated 17-hydroxyprogesterone (17-OHP) levels. Our case reveals that fatal arrhythmias such as a pulseless ventricular tachycardia can be the primary manifestation of the adrenal insufficiency of CAH even in the absence of any physical findings and hence clinicians should always maintain a strong suspicion for CAH in any child presenting with unexplained arrhythmia. Furthermore, this case also highlights the need for CAH screening in neonates so that the appropriate hormone replacement can be initiated before the development of life-threatening adrenal crisis. Cureus 2019-05-24 /pmc/articles/PMC6663285/ /pubmed/31363431 http://dx.doi.org/10.7759/cureus.4749 Text en Copyright © 2019, Manzoor et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Cardiology Manzoor, Nida Minhaj, Areeba Akmal, Manahil Congenital Adrenal Hyperplasia Presenting as Pulseless Ventricular Tachycardia in a Neonate |
title | Congenital Adrenal Hyperplasia Presenting as Pulseless Ventricular Tachycardia in a Neonate |
title_full | Congenital Adrenal Hyperplasia Presenting as Pulseless Ventricular Tachycardia in a Neonate |
title_fullStr | Congenital Adrenal Hyperplasia Presenting as Pulseless Ventricular Tachycardia in a Neonate |
title_full_unstemmed | Congenital Adrenal Hyperplasia Presenting as Pulseless Ventricular Tachycardia in a Neonate |
title_short | Congenital Adrenal Hyperplasia Presenting as Pulseless Ventricular Tachycardia in a Neonate |
title_sort | congenital adrenal hyperplasia presenting as pulseless ventricular tachycardia in a neonate |
topic | Cardiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663285/ https://www.ncbi.nlm.nih.gov/pubmed/31363431 http://dx.doi.org/10.7759/cureus.4749 |
work_keys_str_mv | AT manzoornida congenitaladrenalhyperplasiapresentingaspulselessventriculartachycardiainaneonate AT minhajareeba congenitaladrenalhyperplasiapresentingaspulselessventriculartachycardiainaneonate AT akmalmanahil congenitaladrenalhyperplasiapresentingaspulselessventriculartachycardiainaneonate |